Raloxifene 1200 mg 20 mg/60 Capsules In PakistanInformation, Results, Side Effects, Reviews
Raloxifene 1200 mg 20 mg/60 Capsules In Pakistan
Raloxifene, developed in 1997 and sold under the brand name Evista, among others, is a medication used to reduce breast cancer risk in postmenopausal women with osteoporosis. Raloxifene was first presented in 1997 to help with post-menopausal osteoporosis and was subsequently approved in 1999. Its effect on the reduction on breast cancer risk was also accepted in 2007.
Raloxifene capsules is indicated for the treatment and prevention of osteoporosis in postmenopausal ladies. It is also used for the treatment and reduction of the risk of invasive breast cancer. Raloxifene is effective in combating gynecomastia.
Raloxifene tablets is contraindicated in lactating and pregnant women or women suspecting pregnancy.
It may also be a concern to women with an active or past history of venous thromboembolic events, including deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis. You should never take a higher dosage than the doctor prescribes.
Other Names: Keoxifene; Pharoxifene; LY-139481; LY-156758; CCRIS-7129
Total Amount of the Active Ingredient: 1200 mg
Quantity: 60caps
Packaging: capsulated, bottled
Label:L: 14cm X W: 5,7cm
Submit Your Review ForRaloxifene 1200 mg 20 mg/60 Capsules In Pakistan
Your email address will not be published. Required fields are marked *











